Zhejiang, China

Liman Shang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Liman Shang in Vascular Technology

Introduction

Liman Shang is a notable inventor based in Zhejiang, China, recognized for his contributions to vascular technology. With a total of two patents to his name, he has made significant advancements in medical devices aimed at improving patient outcomes.

Latest Patents

Liman Shang's latest patents include a vascular shunt frame and a multi-lumen stent graft. The vascular shunt frame features a main body tube with a sealing covering that includes a main blood flow opening. This design allows for improved apposition, ensuring that the sealing covering fits closely to the outer surface of the main body stent, thereby preventing endoleaks. The multi-lumen stent graft consists of a tubular main body stent graft and a connection stent graft, designed to minimize endoleaks and displacement. This innovation simplifies surgical operations and reduces the associated risks, making it applicable in a wide range of medical scenarios.

Career Highlights

Liman Shang is currently employed at Hangzhou Endonom Medtech Co. Ltd., where he continues to develop innovative medical technologies. His work focuses on enhancing the effectiveness and safety of vascular interventions.

Collaborations

Liman collaborates with talented professionals in his field, including Wei Guo and Yongsheng Wang. Their combined expertise contributes to the advancement of medical technology and innovation.

Conclusion

Liman Shang's contributions to vascular technology through his patents demonstrate his commitment to improving medical devices. His work not only enhances surgical procedures but also aims to improve patient safety and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…